(MedPage Today) — The FDA approved a gemcitabine intravesical system (Inlexzo) for adults with non-muscle-invasive bladder cancer (NMIBC), the agency announced on Tuesday.
The indication for the nucleoside metabolic inhibitor chemotherapy-containing…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/117396
Author :
Publish date : 2025-09-10 16:29:00
Copyright for syndicated content belongs to the linked Source.
